Concepedia

David E Ambrose

DE

Statistics

Publications

14

Citations

6.2K

H-Index

13

Active since

2013

Affiliations

University of Pennsylvania(Current)

Novartis (United States)

Children's Hospital of Philadelphia

Parker Institute for Cancer Immunotherapy

Philadelphia University

David E Ambrose is an author at University of Pennsylvania specializing in immunotherapy, cancer immunology, and immunology.

Publications per year

2013–2022

14

Publications

14

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.8K citations · Full text

, , +16

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

David Porter, Wei‐Ting Hwang, Noelle V. Frey et al. · Science Translational Medicine · 2015 · 1.7K citations · Full text

, , +14

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

J. Joseph Melenhorst, Gregory M. Chen, Meng Wang et al. · Nature · 2022 · 920 citations · Full text

, , +14

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text

, , +14

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Marco Ruella, Jun Xu, David M. Barrett et al. · Nature Medicine · 2018 · 645 citations · Full text

, , +12

1–5 of 14